Ms Sue Macleman
Non-Executive Director
Board of Director
RHS
Australia
Biography
Ms MacLeman has enjoyed a distinguished career in biotechnology, having worked initially in hospital pharmacy roles before moving to the pharmaceuticals industry in development and commercialisation roles with Merck, Amgen and Bristol-Myers Squibb. She has also been CEO and a Board member of a number of publicly-listed companies in both the United States and Australia. Most recently Ms MacLeman was global Head of Commercial for Mesoblast Ltd. Ms MacLeman is currently a director of Oventus Medical Ltd and was recently appointed as the Chief Executive Officer of the Medical Technologies and Pharmaceuticals Industry Innovation Growth Centre (MTPConnect) and will commence in her role in April 2016.
Research Interest
Biotechnology
